|
ARMCX1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.39500000229509E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.612110E-04 |
| Normal-vs-Stage2 |
1.300010E-03 |
| Normal-vs-Stage3 |
2.37900000032987E-07 |
| Normal-vs-Stage4 |
7.80250000054217E-07 |
| Stage1-vs-Stage2 |
2.660600E-01 |
| Stage1-vs-Stage3 |
3.136300E-02 |
| Stage1-vs-Stage4 |
2.897800E-02 |
| Stage2-vs-Stage3 |
6.706400E-01 |
| Stage2-vs-Stage4 |
5.395200E-01 |
| Stage3-vs-Stage4 |
7.885600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.29179999819718E-08 |
| Normal-vs-AfricanAmerican |
4.515900E-02 |
| Normal-vs-Asian |
2.639000E-03 |
| Caucasian-vs-AfricanAmerican |
5.543200E-01 |
| Caucasian-vs-Asian |
4.167400E-01 |
| AfricanAmerican-vs-Asian |
4.236600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.37909999975427E-07 |
| Normal-vs-Female |
4.86809999999949E-06 |
| Male-vs-Female |
8.038000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.020040E-01 |
| Normal-vs-Age(41-60Yrs) |
3.211400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.08600003936965E-09 |
| Normal-vs-Age(81-100Yrs) |
8.231700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.983800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.745600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.110600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.584100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.295420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.090600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.604400E-01 |
| Normal-vs-Grade 2 |
1.318510E-03 |
| Normal-vs-Grade 3 |
8.56539994487093E-09 |
| Normal-vs-Grade 4 |
1.21570531419479E-11 |
| Grade 1-vs-Grade 2 |
9.482400E-02 |
| Grade 1-vs-Grade 3 |
3.734400E-02 |
| Grade 1-vs-Grade 4 |
1.090040E-02 |
| Grade 2-vs-Grade 3 |
3.183400E-03 |
| Grade 2-vs-Grade 4 |
8.87310000030617E-07 |
| Grade 3-vs-Grade 4 |
6.944500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.529760E-02 |
| Normal-vs-ccB subtype |
1.24099619469575E-11 |
| ccA subtype-vs-ccB subtype |
2.27829999976947E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48290000001605E-06 |
| Normal-vs-N1 |
1.11829999704938E-08 |
| N0-vs-N1 |
1.322460E-02 |
|
|
